Impact of cannabis legalization on healthcare utilization for psychosis and schizophrenia in Colorado

被引:22
作者
Wang, George Sam [1 ]
Buttorff, Christine [2 ]
Wilks, Asa [3 ]
Schwam, Daniel [2 ]
Tung, Gregory [4 ]
Pacula, Rosalie Liccardo [5 ]
机构
[1] Univ Colorado Anschutz Med Campus Childrens, Hosp Colorado, Dept Pediat, 13123 East 16th Ave B251, Aurora, CO 80045 USA
[2] RAND Corp, 1200 S Hayes St, Arlington, VA 22202 USA
[3] RAND Corp, 1776 Main St, Santa Monica, CA 90407 USA
[4] Univ Colorado Anschutz Med Campus, Colorado Sch Publ Hlth, Program Injury Prevent Educ & Res, Dept Hlth Syst Management & Policy, 13001 E 17th Pl,MS B119, Aurora, CO USA
[5] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Sol Price Sch Publ Policy, 635 Downey Way,VPD 514J, Los Angeles, CA 90089 USA
关键词
Cannabis; Legalization; Psychosis; Schizophrenia; Mental health; Marijuana; MARIJUANA; INDIVIDUALS; POTENCY; LONDON;
D O I
10.1016/j.drugpo.2022.103685
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Emergency department (ED) visits involving psychosis and schizophrenia have increased at a rate exceeding population growth in the United States over the past decade. Research shows a strong dose-response relationship between chronic use of high-potency cannabis and odds of developing symptoms of psychosis. The aim of this study was to evaluate the impact of cannabis legalization on psychosis and schizophrenia-related ED visits in Colorado.Methods: Using administrative data from Colorado Hospital Association (CHA) on county-level quarterly ED visits between January 1, 2013, and December 31, 2018, we applied a difference-in-difference analysis to examine how new exposure to recreational cannabis dispensaries after 2014 differentially influenced the rate of ED visits for psychosis and schizophrenia, comparing counties with no prior medical cannabis dispensary exposure to counties with low or high medical dispensary exposure.Results: As recreational dispensaries per 10,000 residents increased, there was no significant association with the rate of schizophrenia ED visits per capita (incidence rate ratio or IRR: 0.95, 95% CI [0.69, 1.30]) while the rate of psychosis visits increased 24% (IRR: 1.24, 95% CI [1.02, 1.49]). Counties with no previous medical dispensaries experienced larger increases in schizophrenia ED visits than counties already exposed to a low level of medical dispensaries, but this effect was not significant. Counties with low baseline medical exposure had lower increases in rates of psychosis visits than counties with high baseline medical exposure (IRR 0.83, 95% CI [0.69, 0.99]). Conclusions: There was a positive association between the number of cannabis dispensaries and rates of psychosis ED visits across all counties in Colorado. Although it is unclear whether it is access to products, or the types of products that may be driving this association, our findings suggest there is a potential impact on the mental health of the local population that is observed after cannabis legalization.
引用
收藏
页数:7
相关论文
共 33 条
[1]  
[Anonymous], Local Area Unemployment Statistics
[2]   Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999 [J].
Boydell, J. ;
Van Os, J. ;
Caspi, A. ;
Kennedy, N. ;
Giouroukou, E. ;
Fearon, P. ;
Farrell, M. ;
Murray, R. M. .
PSYCHOLOGICAL MEDICINE, 2006, 36 (10) :1441-1446
[3]   Mapping cannabis potency in medical and recreational programs in the United States [J].
Cash, Mary Catherine ;
Cunnane, Katharine ;
Fan, Chuyin ;
Romero-Sandoval, E. Alfonso .
PLOS ONE, 2020, 15 (03)
[4]   The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis [J].
D'Souza, DC ;
Perry, E ;
MacDougall, L ;
Ammerman, Y ;
Cooper, T ;
Wu, YT ;
Braley, G ;
Gueorguieva, R ;
Krystal, JH .
NEUROPSYCHOPHARMACOLOGY, 2004, 29 (08) :1558-1572
[5]   Price and product variation in Washington's recreational cannabis market [J].
Davenport, Steven .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2021, 91
[6]   The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study [J].
Di Forti, Marta ;
Quattrone, Diego ;
Freeman, Tom P. ;
Tripoli, Giada ;
Gayer-Anderson, Charlotte ;
Quigley, Harriet ;
Rodriguez, Victoria ;
Jongsma, Hannah E. ;
Ferraro, Laura ;
La Cascia, Caterina ;
La Barbera, Daniele ;
Tarricone, Ilaria ;
Berardi, Domenico ;
Szoke, Andrei ;
Arango, Celso ;
Tortelli, Andrea ;
Velthorst, Eva ;
Bernardo, Miguel ;
Del-Ben, Cristina Marta ;
Menezes, Paulo Rossi ;
Selten, Jean-Paul ;
Jones, Peter B. ;
Kirkbride, James B. ;
Rutten, Bart P. F. ;
de Haan, Lieuwe ;
Sham, Pak C. ;
van Os, Jim ;
Lewis, Cathryn M. ;
Lynskey, Michael ;
Morgan, Craig ;
Murray, Robin M. .
LANCET PSYCHIATRY, 2019, 6 (05) :427-436
[7]   Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study [J].
Di Forti, Marta ;
Marconi, Arianna ;
Carra, Elena ;
Fraietta, Sara ;
Trotta, Antonella ;
Bonomo, Matteo ;
Bianconi, Francesca ;
Gardner-Sood, Poonam ;
O'Connor, Jennifer ;
Russo, Manuela ;
Stilo, Simona A. ;
Marques, Tiago Reis ;
Mondelli, Valeria ;
Dazzan, Paola ;
Pariante, Carmine ;
David, Anthony S. ;
Gaughran, Fiona ;
Atakan, Zerrin ;
Iyegbe, Conrad ;
Powell, John ;
Morgan, Craig ;
Lynskey, Michael ;
Murray, Robin M. .
LANCET PSYCHIATRY, 2015, 2 (03) :233-238
[8]   The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial [J].
Englund, Amir ;
Atakan, Zerrin ;
Kralj, Aleksandra ;
Tunstall, Nigel ;
Murray, Robin ;
Morrison, Paul .
JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (02) :140-151
[9]   How high: Differences in the developments of cannabis markets in two legalized states [J].
Firth, Caislin L. ;
Davenport, Steven ;
Smart, Rosanna ;
Dilley, Julia A. .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2020, 75
[10]  
Fischer B., 2021, INT J DRUG POLICY